Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- A globally important neglected infectious disease
- Cryptosporidiosis
- Why is it so neglected?
- Why is it so neglected? 1993 onwards
- Cryptosporidium scour
- Economic costs for livestock of Cryptosporidium
- The cost of calf scour
- A brake on development in LMICs
- Is it the most important zoonotic disease globally?
- Different species, different hosts – same disease
- Oocysts
- Life cycle
- Not all Cryptosporidium is the same
- Anthroponotic C. hominis predominates in urban low sanitation environments
- Relationship between Cryptosporidium species
- C. parvum evolves to be more anthroponotic
- C. hominis hominis vs. C. hominis aquapotensis
- Anthroponotic Cryptosporidium is still evolving
- Increased research funding
- New culture systems, new drug assays
- Licensed drugs
- Current (short) pipeline
- GP60: a GPI-linked sporozoite surface antigen
- Immunity, host and microbiome
- New Cryptosporidium vaccine
- Big questions remain
- One Medicine
- One Health
Topics Covered
- Cryptosporidium and cryptosporidiosis
- Neglected infectious disease
- Cryptosporidium scour
- Global effect of cryptosporidiosis
- Zoonotic diseases
- Cryptosporidium hominis and Cryptosporidium parvum
- Anthroponotic Cryptosporidium
- Oocysts
- GP60
- Cryptosporidium treatment and a new vaccine
- One Health approach
Links
Series:
Categories:
Therapeutic Areas:
External Links
- MSF Access campaign: Tropical and neglected diseases
- HSTalk: Ms. Yael Velleman | Water, sanitation and hygiene (WASH) for the prevention and care of NTDs
- HSTalk: Prof. Eric Fèvre | One health challenges of zoonotic NTDs
- HSTalk: Prof. David Molyneux | Introduction to neglected tropical diseases
- MSD animal health hub: The cost of calf scour
Talk Citation
Tyler, K. (2024, July 31). Cryptosporidium and cryptosporidiosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/SVAG2740.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
HSTalks is pleased to grant unrestricted complimentary access to all lectures in the series Neglected Tropical Diseases. Persons not at a subscribing institution should sign up for a personal account.
Other Talks in the Series: Neglected Tropical Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Kevin Tyler.
I'm based at the Norwich
Medical School at
the University of East Anglia
on the Norwich Research Park
where we have one of the
largest communities of
Enteric Microbiologists
in Europe.
Today I'd like to talk to
you about Cryptosporidium,
a neglected disease
which is either
the most important or
one of the most
important causes of
diarrheal disease in terms of
human health and development.
0:27
Cryptosporidiosis is
a globally important
neglected infectious disease.
Globally, infectious
disease remains
the main threat to
young children who
are particularly at
risk of contracting
respiratory, diarrheal, and
vector-spread diseases.
Some half a million
children under five
will die from
diarrheal infections,
which is approaching 10% of
the almost 6 million
deaths in this age group.
The threat is greatest where
sanitation is the poorest.
Of these deaths,
greater than 60,000 per year
are attributable to
Cryptosporidium.
It's about 12% of the total.
This is the largest single group
where no profile
axis is available.
There's no vaccine
for such children
and there are no effective
drugs for their treatment.
1:16
Cryptosporidiosis fits
classical criteria that
have been laid out
by David Molyneux
in his introductory lecture
for a neglected
tropical disease.
It is a disease which
disproportionately
exerts its effects on
impoverished populations
without access to
good sanitation.
The link to sanitation
is indicative that
it is an enteric and water-borne
wash-related disease with
the features laid out in an
earlier lecture by Yael Velleman.
As such, it's one where
primary public
health-related interventions
involve improving water
sanitation and health.
But with the added complication,
as I'll mention later,
it is caused by
an organism which
resists chlorination.
It's a zoonotic disease and,
as I'll come to
later in the talk,
is subject to the
challenges and approaches
laid out by Eric Fevre
in his earlier lecture.
These characteristics of being
chlorination-resistant
and zoonotic mean that
the prevalence of
cryptosporidiosis is global.
It is widespread in
the most as well as
the least developed nations.
However, the vast majority of
the burden of
disease in terms of
morbidity, health,
and development,
fall squarely onto the poorest.
Lack of recognition
of its significance,
until very recently,
has meant that
it is a seriously under-researched
illness in spite of
the lack of an effective
drug or vaccine.